Nanoparticle-Derived Non-Viral Genetic Transfection at the Blood-Brain Barrier to Enable Neuronal Growth Factor Delivery by Secretion from Brain Endothelium

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|22|3330-3334

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.22, 2011-08, pp. : 3330-3334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics and Brain Uptake of Biotinylated Basic Fibroblast Growth Factor Conjugated to a Blood-Brain Barrier Drug Delivery System

By Wu Dafang   Song Bi-Wei   Vinters Harry V.   Pardridge William M.  

Journal of Drug Targeting, Vol. 10, Iss. 3, 2002-01 ,pp. : 239-245

Informa Healthcare

Access to resources Recommend Favorite

Drug delivery to brain via the blood-brain barrier

By Scherrmann J.-M.  

General Pharmacology, Vol. 38, Iss. 6, 2002-06 ,pp. : 349-354

Elsevier

Access to resources Recommend Favorite

Endocytosis at the blood–brain barrier: From basic understanding to drug delivery strategies

By Smith Mathew W.   Gumbleton Mark  

Journal of Drug Targeting, Vol. 14, Iss. 4, 2006-05 ,pp. : 191-214

Informa Healthcare

Access to resources Recommend Favorite

Recent Advances in Delivery Through the Blood-Brain Barrier

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 9, 2014-05 ,pp. : 1148-1160

Bentham Science Publishers

Access to resources Recommend Favorite

Polypeptide Delivery Across The Blood-Brain Barrier

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 2, 2004-04 ,pp. : 131-136

Bentham Science Publishers

Access to resources Recommend Favorite